Philips Ventilator Cancer in Honolulu

Information on FDA Philips Warning for CPAP & BiPAP Cancer for Honolulu Residents

In June of 2021, Royal Philips of the Netherlands announced a widespread global recall of 3-4 million CPAP, BiPAP and ventilator breathing machines due to a risk of developing cancer. Consumers in Honolulu learned they were exposed to a risk of Philips BiPAP cancer when a foam component in the recalled breathing devices begins to degrade or break down. The foam part, which is used for sound abatement, is found in BiPAP, CPAP and ventilators made by Philips; persons in Honolulu using the devices listed in the recall have been exposed to a risk for Philips ventilator cancer.

Honolulu Philips CPAP Cancer

The foam components in question are prone to breaking down over time and through exposure to heat and humidity, as well as through non-recommended cleaning substances such as ozone. The risk of Philips BiPAP cancer in Honolulu occurs when toxic particles and gases from the foam are pushed out through the device's airstream. Honolulu patients breathe this air directly into their lungs through a mask.

According to the FDA, any person using a device that poses a risk for Philips CPAP cancer in Honolulu should stop using that machine immediately, if possible. Sleep apnea patients who have been exposed to the Philips ventilator cancer risk in Honolulu should cease the use of their recalled machine promptly to avoid further danger of Philips CPAP cancer. For patients in Honolulu who are reliant on a life-supporting mechanical ventilator included in the Philips cancer recall list, the FDA advises their care provider in Honolulu transfer them to an alternate device if and when possible.

Attorneys handling Philips BiPAP cancer lawsuits in Honolulu believe persons and family members of persons who have developed cancer or another serious side effect and have a history of using one of the recalled machines may be eligible for significant compensation. This page provides a comprehensive look at Philips ventilator cancer risks and warnings for residents of Honolulu.

Honolulu Residents Face Cancer Risk from Philips CPAP, BiPAP and Ventilator Machines

Philips is a major manufacturer of many different medical products and devices, and sells them in Honolulu and on a major global scale. The recall issued by the company in June of 2021 concerned three specific kinds of breathing devices that cause cancer in Honolulu: continuous positive airway pressure or CPAP machines; bilevel positive airway pressure or BiPAP machines; and mechanical ventilators. The first two, CPAP and BiPAP, are used by Honolulu patients suffering from sleep apnea; the latter provides life support to Honolulu patients.

Company officials evidently learned of the risk of Philips ventilator cancer through complaints filed by consumers and medical providers, stating patients were becoming ill as a result of the foam component breaking down. No one knows when the company first learned about the risk for Philips CPAP cancer, but the first external indication of this danger for Honolulu residents came in April of 2021, when Philips noted there had been a “quality issue” detected with these devices.

This first mention of Philips BiPAP cancer came in a shareholder report. The public, including doctors and patients in Honolulu, was not notified until June of 2021, when the company released its ventilator cancer warning and recall that now affects many families in Honolulu.

The risk for Philips CPAP cancer to Honolulu residents comes when a foam component in the device degrades, releasing toxic particles and gases into the device's airflow. These carcinogenic substances are then directly inhaled by Honolulu users of recalled breathing machines.

FDA Philips BiPAP Cancer Warning Information for Honolulu

On June 14, 2021, the Philips CPAP cancer warning and recall was issued for an estimated 3-4 million products in use around the world, including some used by persons in Honolulu. The products included in the recall were those that utilized the problematic foam component and thus posed a risk for ventilator cancer.

The foam component is a substance referred to as PE-PUR, which stands for polyester-based polyurethane. Used to dampen the noise of the machine, this part has been found to degrade over time. Exposure to humidity and heat cause the foam to break down, as can non-approved methods for cleaning a BiPAP machine such as ozone.

The risk for Philips CPAP cancer in Honolulu comes when this part degrades, releasing toxic particles and gases into the device's airflow. These carcinogenic substances are then directly inhaled by the user of a recalled breathing machine in Honolulu. According to the FDA ventilator cancer warning, inhalation of these harmful substances may result in the following problems for Honolulu residents:

Who can file a ventilator recall lawsuit?

Patients who have used one of more than twenty different types of breathing machines included in the Philips CPAP, BiPAP and ventilator recall and then developed cancer or another serious medical problem may be eligible to file a claim against the Dutch manufacturer. Click here to learn more.

The following devices were recalled, citing a risk for Philips BiPAP cancer:

According to the FDA Philips ventilator cancer warning, patients in Honolulu utilizing the recalled devices should be moved to a different machine if at all possible.

Philips Life Support Ventilators Found May Cause Cancer in Honolulu Patients

Roughly half a million of the devices included in the Philips BiPAP cancer recall are life-supporting mechanical ventilators. These devices are an essential tool in Honolulu intensive care units, maintaining ventilation when a patient cannot do so. It is particularly horrible to learn that a device designed to save life in such extreme circumstances also puts Honolulu patients at risk for life-threatening disease when by emitting toxic and carcinogenic substances.

Honolulu FDA CPAP BiPAP Cancer Warning

According to the FDA Philips CPAP cancer warning, medical providers have been instructed to halt the use of these dangerous devices as soon as is feasible in their Honolulu patients.

Philips BiPAP and CPAP Sleep Apnea Machines May Cause Cancer in Honolulu Patients

Approximately 80% of the 3-4 millions breathing machines included in the Philips CPAP cancer recall are devices used to treat sleep apnea in Honolulu. These machines fit into two distinct categories: bilevel PAP machines and CPAP machines. An estimated 20 million Americans suffer from sleep apnea. Untreated, this condition results in poor and disrupted sleep and is a risk factor for stroke, heart problems and premature death.

By supporting continuous and regular breathing throughout sleep, CPAP and BiPAP machines improve health outcomes for Honolulu persons diagnosed with sleep apnea. However, when a device designed to reduce one type of health risk causes another severe health risk for Honolulu residents, Philips BiPAP cancer, it is no surprise that patients are angry. Countless residents of Honolulu and millions of other Americans have been using these sleep apnea devices every night with no prior warning of the risk for cancer. Anyone in Honolulu currently using a machine on the recall list is recommended to stop use of the dangerous device immediately in order to mitigate the risk of Philips CPAP cancer.

Let Our Philips CPAP Cancer Attorneys Serving Honolulu Help You

Our lawyers specialize in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today.

Philips BiPAP Cancer Lawsuits for Honolulu Residents

Filing a lawsuit will allow you to hold the pharmaceutical company accountable for damage it has caused you or a loved one, while also providing real compensation for your medical expenses, suffering and loss. Contact us today for a free consultation.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.